Progestin-containing contraceptives alter expression of host defense-related genes of the endometrium and cervix

Reproductive Sciences

Volumn 22, Issue 7, 2015, Pages 814-828

  Goldfien, Gabriel A ^a   Barragan, Fatima ^a   Chen, Joseph ^a   Takeda, Margaret ^a   Irwin, Juan C ^a   Perry, Jean ^a   Greenblatt, Ruth M ^a   Smith Mccune, Karen K ^a   Giudice, Linda C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cervix; endometrium; gene expression; host defense; progestin based contraceptives

Indexed keywords

COMPLEMENT; FIBRONECTIN; GESTAGEN; HEMOGLOBIN; HOMOGENTISATE 1,2 DIOXYGENASE; HYDROXYSTEROID 17 BETA DEHYDROGENASE 2; MATRILYSIN; MATRIX METALLOPEPTIDASE 26; MATRIX METALLOPEPTIDASE 7; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 26; MEDROXYPROGESTERONE ACETATE; OSTEOPONTIN; PATTERN RECOGNITION RECEPTOR; PROLACTIN; PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOSTATIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; UROPLAKIN 1B; CONTRACEPTIVE AGENT; LEVONORGESTREL;

ADULT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENDOMETRIUM; FEMALE; FEMALE GENITAL SYSTEM; GENE EXPRESSION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; INFECTION SENSITIVITY; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE ADHERENCE; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MIDDLE AGED; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAFETY; UTERINE CERVIX; YOUNG ADULT; ADOLESCENT; DRUG EFFECTS; GENE EXPRESSION REGULATION;

ADOLESCENT; ADULT; CERVIX UTERI; CONTRACEPTIVE AGENTS, FEMALE; CROSS-SECTIONAL STUDIES; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; PROGESTINS; YOUNG ADULT;

EID: 84936107091     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719114565035     Document Type: Article

References (63)

1. Nations U. World Contraceptive Use 2009. In: contracept2009-wallchart-front.pdf, ed. New York: United Nations Population Division; 2009.
2. Guttinger A, Critchley HO,. Endometrial effects of intrauterine levonorgestrel. Contraception. 2007; 75 (6 suppl): S93-S98.
3. Song JY, Fraser IS,. Effects of progestogens on human endometrium. Obst Gynecol Surv. 1995; 50 (5): 385-394.
4. Polis CB, Curtis KM,. Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. Lancet Infect Dis. 2013; 13 (9): 797-808.
5. Rodriguez-Garcia M, Patel MV, Wira CR,. Innate and adaptive anti-HIV immune responses in the female reproductive tract. J Reprod Immunol. 2013; 97 (1): 74-84.
6. Wira CR, Fahey JV,. A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS. 2008; 22 (15): 1909-1917.
7. Patton DL, Thwin SS, Meier A, Hooton TM, Stapleton AE, Eschenbach DA,. Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle. Am J Obstet Gynecol. 2000; 183 (4): 967-973.
8. Shacklett BL, Greenblatt RM,. Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implications. Am J Reprod Immunol. 2011; 65 (3): 230-241.
9. Talbi S, Hamilton AE, Vo KC,. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology. 2006; 147 (3): 1097-1121.
10. Saba E, Origoni M, Taccagni G,. Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle. Mucosal Immunol. 2013; 6 (6): 1081-1090.
11. Hladik F, Hope TJ,. HIV infection of the genital mucosa in women. Curr HIV/AIDS Rep. 2009; 6 (1): 20-28.
12. Barnhart KT, Stolpen A, Pretorius ES, Malamud D,. Distribution of a spermicide containing Nonoxynol-9 in the vaginal canal and the upper female reproductive tract. Hum Reprod. 2001; 16 (6): 1151-1154.
13. Dayal MB, Wheeler J, Williams CJ, Barnhart KT,. Disruption of the upper female reproductive tract epithelium by nonoxynol-9. Contraception. 2003; 68 (4): 273-279.
14. Zhang Z,. Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4+ T Cells. Science. 1999; 286 (5443): 1353-1357.
15. Asin SN, Fanger MW, Wildt-Perinic D, Ware PL, Wira CR, Howell AL,. Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts. J Infect Dis. 2004; 190 (2): 236-245.
16. Aghajanova L, Tatsumi K, Horcajadas JA,. Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis. Biol Reprod. 2011; 84 (4): 801-815.
17. Piltonen TT, Chen J, Erikson DW,. Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential. J Clin Endocrinol Metab. 2013; 98 (9): 3765-3775.
18. Aghajanova L, Horcajadas JA, Weeks JL,. The protein kinase A pathway-regulated transcriptome of endometrial stromal fibroblasts reveals compromised differentiation and persistent proliferative potential in endometriosis. Endocrinology. 2010; 151 (3): 1341-1355.
19. Dixon W,. Analysis of Extreme Values. Ann Math Stat. 1950; 21 (4): 488-506.
20. Richards RG, Brar AK, Frank GR, Hartman SM, Jikihara H,. Fibroblast cells from term human decidua closely resemble endometrial stromal cells: induction of prolactin and insulin-like growth factor binding protein-1 expression. Biol Reprod. 1995; 52 (3): 609-615.
21. Pudney J, Quayle AJ, Anderson DJ,. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod. 2005; 73 (6): 1253-1263.
22. Jones RL, Morison NB, Hannan NJ, Critchley HO, Salamonsen LA,. Chemokine expression is dysregulated in the endometrium of women using progestin-only contraceptives and correlates to elevated recruitment of distinct leukocyte populations. Human reproduction. 2005; 20 (10): 2724-2735.
23. Song JY, Russell P, Markham R, Manconi F, Fraser IS,. Effects of high dose progestogens on white cells and necrosis in human endometrium. Hum Reprod. 1996; 11 (8): 1713-1718.
24. Myer L, Wright TC Jr, Denny L, Kuhn L,. Nested case-control study of cervical mucosal lesions, ectopy, and incident HIV infection among women in Cape Town, South Africa. Sex Transm Dis. 2006; 33 (11): 683-687.
25. Gellersen B, Brosens J,. Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair. J Endocrinol. 2003; 178 (3): 357-372.
26. Bell SC, Jackson JA, Ashmore J, Zhu HH, Tseng L,. Regulation of insulin-like growth factor-binding protein-1 synthesis and secretion by progestin and relaxin in long term cultures of human endometrial stromal cells. J Clin Endocrinol Metab. 1991; 72 (5): 1014-1024.
27. Zhu HH, Huang JR, Mazella J, Rosenberg M, Tseng L,. Differential effects of progestin and relaxin on the synthesis and secretion of immunoreactive prolactin in long term culture of human endometrial stromal cells. J Clin Endocrinol Metab. 1990; 71 (4): 889-899.
28. Brar AK, Frank GR, Richards RG,. Laminin decreases PRL and IGFBP-1 expression during in vitro decidualization of human endometrial stromal cells. J Cell Physiol. 1995; 163 (1): 30-37.
29. Burton KA, Henderson TA, Hillier SG,. Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium. Hum Reprod. 2003; 18 (12): 2610-2617.
30. Horcajadas JA, Sharkey AM, Catalano RD,. Effect of an intrauterine device on the gene expression profile of the endometrium. J Clin Endocrinol Metab. 2006; 91 (8): 3199-3207.
31. Wilkinson J, Cunningham AL,. Mucosal transmission of HIV-1: first stop dendritic cells. Curr Drug Targets. 2006; 7 (12): 1563-1569.
32. Morrow G, Vachot L, Vagenas P, Robbiani M,. Current concepts of HIV transmission. Curr HIV/AIDS Rep. 2007; 4 (1): 29-35.
33. Hirbod T, Kaldensjo T, Broliden K,. In situ distribution of HIV-binding CCR5 and C-type lectin receptors in the human endocervical mucosa. PLoS One. 2011; 6 (9): e25551.
34. Kaldensjo T, Petersson P, Tolf A, Morgan G, Broliden K, Hirbod T,. Detection of intraepithelial and stromal Langerin and CCR5 positive cells in the human endometrium: potential targets for HIV infection. PLoS One. 2011; 6 (6): e21344.
35. Rescigno M, Urbano M, Valzasina B,. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol. 2001; 2 (4): 361-367.
36. Pope M, Gezelter S, Gallo N, Hoffman L, Steinman RM,. Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells. J Exp Med. 1995; 182 (6): 2045-2056.
37. Rinaldo CR,. HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells. Scientifica (Cairo). 2013; 2013: 164203.
38. Kawamura T, Gulden FO, Sugaya M,. R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms. Proc Natl Acad Sci U S A. 2003; 100 (14): 8401-8406.
39. Kammerer U, von Wolff M, Markert UR,. Immunology of human endometrium. Immunobiology. 2004; 209 (7): 569-574.
40. Mor G, Cardenas I, Abrahams V, Guller S,. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci. 2011; 1221: 80-87.
41. Burke SD, Barrette VF, Gravel J,. Uterine NK cells, spiral artery modification and the regulation of blood pressure during mouse pregnancy. Am J Reprod Immunol. 2010; 63 (6): 472-481.
42. Plaks V, Birnberg T, Berkutzki T,. Uterine DCs are crucial for decidua formation during embryo implantation in mice. J Clin Invest. 2008; 118 (12): 3954-3965.
43. Aluvihare VR, Kallikourdis M, Betz AG,. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. 2004; 5 (3): 266-271.
44. Laskarin G, Kammerer U, Rukavina D, Thomson AW, Fernandez N, Blois SM,. Antigen-presenting cells and materno-fetal tolerance: an emerging role for dendritic cells. Am J Reprod Immunol. 2007; 58 (3): 255-267.
45. Rhen T, Cidlowski JA,. Estrogens and glucocorticoids have opposing effects on the amount and latent activity of complement proteins in the rat uterus. Biol Reprod. 2006; 74 (2): 265-274.
46. Roopa BA, Loganath A, Singh K,. The effect of a levonorgestrel-releasing intrauterine system on angiogenic growth factors in the endometrium. Hum Reprod. 2003; 18 (9): 1809-1819.
47. Labied S, Galant C, Nisolle M,. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time. Hum Reprod. 2009; 24 (1): 113-121.
48. Lockwood CJ,. Mechanisms of normal and abnormal endometrial bleeding. Menopause. 2011; 18 (4): 408-411.
49. Bokstrom H, Norstrom A,. Effects of mifepristone and progesterone on collagen synthesis in the human uterine cervix. Contraception. 1995; 51 (4): 249-254.
50. Westergren-Thorsson G, Norman M, Bjornsson S,. Differential expressions of mRNA for proteoglycans, collagens and transforming growth factor-beta in the human cervix during pregnancy and involution. Biochim Biophys Acta. 1998; 1406 (2): 203-213.
51. Schlembach D, Mackay L, Shi L, Maner WL, Garfield RE, Maul H,. Cervical ripening and insufficiency: from biochemical and molecular studies to in vivo clinical examination. Eur J Obstet Gynecol Reprod Biol. 2009; 144 (suppl 1): S70-S76.
52. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M,. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 2003; 188 (2): 419-424.
53. Saghafi N, Khadem N, Mohajeri T, Shakeri MT,. Efficacy of 17alpha-hydroxyprogesterone caproate in prevention of preterm delivery. J Obstet Gynaecol Res. 2011; 37 (10): 1342-1345.
54. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH, Fetal Medicine Foundation Second Trimester Screening G. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 2007; 357 (5): 462-469.
55. Yellon SM, Ebner CA, Elovitz MA,. Medroxyprogesterone acetate modulates remodeling, immune cell census, and nerve fibers in the cervix of a mouse model for inflammation-induced preterm birth. Reprod Sci. 2009; 16 (3): 257-264.
56. Ekman-Ordeberg G, Stjernholm Y, Wang H, Stygar D, Sahlin L,. Endocrine regulation of cervical ripening in humans - potential roles for gonadal steroids and insulin-like growth factor-I. Steroids. 2003; 68 (10-13): 837-847.
57. House M, Tadesse-Telila S, Norwitz ER, Socrate S, Kaplan DL,. Inhibitory effect of progesterone on cervical tissue formation in a three-dimensional culture system with human cervical fibroblasts. Biol Reprod. 2014; 90 (1): 18.
58. Tornblom SA, Patel FA, Bystrom B,. 15-hydroxyprostaglandin dehydrogenase and cyclooxygenase 2 messenger ribonucleic acid expression and immunohistochemical localization in human cervical tissue during term and preterm labor. J Clin Endocrinol Metab. 2004; 89 (6): 2909-2915.
59. Farina M, Ribeiro ML, Weissmann C,. Biosynthesis and catabolism of prostaglandin F2alpha (PGF2alpha) are controlled by progesterone in the rat uterus during pregnancy. J Steroid Biochem Mol Biol. 2004; 91 (4-5): 211-218.
60. Tilley SL, Coffman TM, Koller BH,. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest. 2001; 108 (1): 15-23.
61. Kelly RW,. Inflammatory mediators and cervical ripening. J Reprod Immunol. 2002; 57 (1-2): 217-224.
62. Young A, Thomson AJ, Ledingham M, Jordan F, Greer IA, Norman JE,. Immunolocalization of proinflammatory cytokines in myometrium, cervix, and fetal membranes during human parturition at term. Biol Reprod. 2002; 66 (2): 445-449.
63. Osman I, Young A, Ledingham MA,. Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod. 2003; 9 (1): 41-45.